WIA
PROF

Wetzel Investment Advisors’s Profound Medical PROF Stock Holding History

Wetzel Investment Advisors’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,000
Closed -$17.1K – 697
2024
Q2 		$17.1K Hold
2,000
– – 0.01% 369
2024
Q1 		$15.7K Hold
2,000
– – 0.01% 422
2023
Q4 		$17K Buy
+2,000
New +$19K 0.01% 413

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Wetzel Investment Advisors's PROF Position: Q3 2024 in Review

Wetzel Investment Advisors sold out of Profound Medical (PROF) in Q3 2024, closing a stake of 2,000 shares — an estimated $17.1K sold.

Wetzel Investment Advisors first reported a position in PROF in Q4 2023 and held it in 3 quarters. The position peaked at $17.1K in Q2 2024. 44 funds tracked by Wall St. Rank hold PROF as of Q3 2024.

  • Wetzel Investment Advisors reported no remaining Profound Medical position as of Q3 2024 after selling out during the quarter.
  • Wetzel Investment Advisors sold 2,000 Profound Medical shares in Q3 2024, an estimated $17.1K.
  • Wetzel Investment Advisors first reported a position in Profound Medical in Q4 2023 and held it in 3 quarters.
  • Wetzel Investment Advisors's Profound Medical position peaked at $17.1K in Q2 2024.
  • 44 funds tracked by Wall St. Rank held Profound Medical as of Q3 2024.

Based on Wetzel Investment Advisors's 13F filing for Q3 2024, filed 29 Oct 2024.